508.460.8822 Contact Us

Publications

Chang BH, Pitluk ZW, Farina DJ. Development of a positive control on assessing the effects of bubble formation on actuation profiles for nasal spray drug delivery devices. Annual Meeting of the American Association of Pharmaceutical Sciences. 2011; Poster number T2346. Contact the American Association of Pharmaceutical Scientists for further information.

Continue Reading

Prince IR, Chang BH, Pitluk ZW, Farina DJ. Consideration of human actuation parameters on choice of appropriate drug and device combinations for nasal and aerosol delivery devices. Annual Meeting of the American Association of Pharmaceutical Sciences. 2010; Poster number T3230. Contact the American Association of Pharmaceutical Scientists for further information.

Continue Reading

Journal of Aerosol Medicine and Pulmonary Drug Delivery, 23(2):77-89 (April 2010). Makidon PE1, Nigavekar SS, Bielinska AU, Mank N, Shetty AM, Suman J, Knowlton J, Myc A, Rook T, Baker JR Jr. Corresponding author: pmakidon@umich.edu 1Michigan Nanotechnology Institute for Medicine and Biological Sciences, University of Michigan, Ann Arbor, Michigan 48109-5648, USA. Abstract Background: Many infectious diseases that cause significant morbidity and mortality, especially in the […]

Continue Reading

Journal of Pharmaceutical Sciences, 99(4):2114-2122 (April 2010). Guo C1, Doub WH, Kauffman JF. Corresponding author: changning.guo@fda.hhs.gov 1Division of Pharmaceutical Analysis, U.S. Food and Drug Administration, 1114 Market Street, Room 1002, St. Louis, Missouri 63101 Abstract Design of experiment (DOE) methodology can provide a complete evaluation of the influences of nasal spray activation and formulation properties on delivery performance […]

Continue Reading

Int J Pharm. 2010 Mar 30;388(1-2):82-7. doi: 10.1016/j.ijpharm.2009.12.041. Epub 2010 Jan 5. Liu X1, Doub WH, Guo C. U.S. Food & Drug Administration, Division of Pharmaceutical Analysis, 1114 Market Street, Room 1002, St. Louis, MO 63101, United States   Abstract To determine aerosol deposition during the inhalation drug delivery, it is important to understand the combination of velocity […]

Continue Reading

Farina DJ, LeBlanc SG. Investigation of the design space sensitivity for in vitro testing of commercially available nasal sprays using a statistical, Quality by Design approach. Inhaled and Nasal Technology Focus Group of the American Association of Pharmaceutical Sciences. 2009. Contact Inhaled and Nasal Technology Focus Group of the American Association of Pharmaceutical Scientists for […]

Continue Reading

Filter publications by

 
"Proveris Scientific Corporation provides expert support for nasal developers. They are fast, reliable and are professionals at installing of their equipment and supports in demanding challenges." Dr. Peter Svete, Head of Physical Analytics, Lek Pharmaceuticals d.d.
 
 
"Proveris provides insightful and thorough test services. We would recommend working with Proveris. Proveris has great expertise in spray analysis." Elaine Schutte, Chief Development Officer, ProFibrix
 
 
"I want to express my sincere gratitude towards Proveris and the service team for being there to make sure our study goes well. The study just completed few minutes ago and thankfully everything went well.......while we conducted SAC study. It was a great display of professionalism by Proveris." ,
 
 
"As customary, Proveris's service team provided excellent service and was able to answer my questions." ,
 
 
"Thank you for the thorough training on our new equipment. I wish more companies would implement your hands on approach when it comes to training. Thanks again." ,
 
 
“We really appreciate the creativity and work conducted at Proveris for their Test Services (Proveris by Design®). Their knowledge, experience, and insight with OINDP’s was very helpful. Thanks to the Proveris team, we have a wonderful solution that we can use for commercial products!” Mic Iwashima, NDS Division, Shin Nippon Biomedical Laboratories, Ltd